Consensus statement of the Spanish Association Of Urology on the use of meshes in pelvic organ prolapse

INTRODUCTION

Recently the Food and Drug Administration has banned the use of transvaginal meshes for the surgical treatment of pelvic organ prolapse (POP) in the United States. This has caused a worldwide impact on the management of pelvic floor pathology by different specialists.

OBJECTIVE

To achieve a consensus on the use of meshes in the surgical treatment of POPs.

ACQUISITION OF DATA/EVIDENCE

A Committee of experts of the Spanish Association of Urology (AEU) was organized to review the literature and analyze the safety and efficacy of the use of polypropylene meshes in POP surgery.

RESULTS/EVIDENCE FROM THE LITERATURE

The evidence reflects that the use of meshes, compared to the use of native tissues, offers better efficacy at the expense of new complications and a higher rate of surgical reviews, these being minor in the hands of expert surgeons.

CONCLUSIONS

POP surgery must be performed by experienced surgeons, properly trained and in referral centers. The patient should receive correct information about the different treatment options. Transvaginal meshes should only be indicated in complex cases and in recurrences after POP surgery.

AEU PROPOSAL

Creation of a clinical guideline and a national registry for long-term evaluation. Preparation of an Informed Consent available to all professionals and patients, as well as a specific training plan to achieve better training in complex pelvic floor surgery.